DOCSLIB.ORG

UCP2 Overexpression Enhanced Glycolysis Via Activation of PFKFB2 During Skin Cell Transformation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
UCP2 Overexpression Enhanced Glycolysis Via Activation of PFKFB2 During Skin Cell Transformation www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 56), pp: 95504-95515 Research Paper UCP2 overexpression enhanced glycolysis via activation of PFKFB2 during skin cell transformation Annapoorna Sreedhar1, Petra Petruska1, Sumitra Miriyala2, Manikandan Panchatcharam2 and Yunfeng Zhao1 1Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA 2Department of Anatomy and Cell Biology, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA Correspondence to: Yunfeng Zhao, email: [email protected] Keywords: mitochondrial uncoupling 2; PFKFB2; mitochondria; glycolysis; skin cells Received: June 24, 2017 Accepted: August 03, 2017 Published: September 08, 2017 Copyright: Sreedhar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Uncoupling protein 2 (UCP2) is an inner mitochondrial membrane transporter which is often upregulated in human cancers. However, how this anion transporter affects tumorigenesis is not well understood. Using the skin cell transformation JB6 model, we demonstrated that UCP2 overexpression activated phosphofructokinase 2/ fructose-2,6-bisphosphatase 2 (PFKFB2), a key regulator of glycolysis. In conjunction, upregulation of PFKFB2 expression correlated with elevated fructose 2,6-bisphosphate (Fru-2,6-P2) levels, 6-phosphofructo-1-kinase (PFK-1) activity, glucose uptake, and lactate production. Inhibiting PFKFB2 expression suppressed UCP2-mediated skin cell transformation, decreased cell proliferation, and enhanced mitochondrial respiration, while dampening aerobic glycolysis. The AKT signaling pathway was activated in the UCP2 overexpressed cells; furthermore, the activated AKT signaling contributed to the activation of PFKFB2. Whereas AKT inactivation blocked PFKFB2 activation, suggesting that AKT activation is an important step in PFKFB2 activation. Collectively, our data suggest that UCP2 is a critical regulator of cellular metabolism during cell transformation. Our data also demonstrate a potentially novel mechanism to understand UCP2’s tumor-promoting role, which is through the AKT-dependent activation of PFKFB2 and thereby, the metabolic shift to glycolysis (the Warburg effect). INTRODUCTION According to a recent review by Hanahan and Weinberg [1], much attention has been given to a Unlike normal cells, cancer cells are characterized dysregulated metabolism as an emerging hallmark by uncontrolled growth, enhanced proliferation, and of cancer cells with a primary focus directed at the replicative immortality [1]. Cancer cells often reprogram dependence of tumor cells on enhanced glycolysis [10– their metabolism to fuel their accelerated growth [2]. This 13]. This realization has brought renewed attention to the observation was first made by Otto Warburg, one of the Warburg effect, and this metabolic alteration of tumor pioneers in the field of cancer metabolism, who claimed cells is being extensively studied. that the root cause of cancer is too much acidity in the Cancer cells undergo various metabolic and body [3–5]. In other words, the Warburg effect is the autonomous changes that drive tumorigenesis [11, 14]. In observation that cancer cells heavily depend on glycolysis addition to our work, other studies have also suggested leading to lactic acid production even in the presence of that one such driver of tumorigenesis is the mitochondrial oxygen [6–7]. However, the definitive reason for this uncoupling protein 2 (UCP2) [15–16]. Uncoupling observation remained debatable [8–9]. proteins are a family of anion transporters present www.impactjournals.com/oncotarget 95504 Oncotarget in the inner mitochondrial membrane whose protein RESULTS expressions are closely related to changes during cell proliferation and tumorigenesis [16–19]. We and others Glycolysis versus mitochondrial respiration in have demonstrated that UCP2 is often highly expressed UCP2 overexpressed cells in human cancers [20–22]. Although the exact role of UCP2 during carcinogenesis remains elusive, studies To understand how upregulated UCP2 affects from our lab (manuscript under review) and others’ cellular bioenergetics, oxygen consumption rate (OCR) research demonstrate that UCP2 is a crucial player in and extracellular acidification rate (ECAR), as indicators of the cascade of mitochondrial molecular events, redox mitochondrial respiration and glycolytic rate, respectively, regulation, cell cycle, cell proliferation, cell survival, were measured. The measurements were taken using a and apoptosis [23–26]. Since UCP2 overexpression is Seahorse Bioscience XF Analyzer in control pCMV cells closely associated with enhanced cell proliferation and and UCP2 overexpressed cells [35–36]. Modulators of tumorigenesis, targeting UCP2 expression may be a oxidative phosphorylation such as oligomycin, FCCP, winning therapeutic strategy to treat UCP2 overexpressed and antimycin/rotenone were added sequentially to the cancers. Moreover, it was recently reported that UCP2 cells and OCR was determined. The basal OCR rates is not just an uncoupling protein but also a metabolite were 255 pmol/min in pCMV cells and 170 pmol/min transporter [27]. This observation would put UCP2 in in UCP2 overexpressed cells; and TPA treatment further a position to influence cellular metabolism in favor of reduced the basal OCR rates (Figure 1A). To determine tumorigenesis. Hence, it is important to understand the the maximal capacity of these cells, p-trifluoromethoxy molecular basis of UCP2 overexpression in tumor cell carbonyl cyanide phenyl hydrazone (FCCP), an uncoupler metabolism, differentiation, and survival. Therefore, in an was added to the respiring cells. The maximal respiratory attempt to understand how UCP2 regulates cellular energy rate as determined by FCCP was significantly lower in metabolism during skin carcinogenesis, we performed a the UCP2 overexpressed cells compared to the control protein microarray analysis using the skin tumor tissues pCMV cells (Figure 1A). Mitochondrial reserve capacity, obtained from wild-type and UCP2 knockout mice at the amount of oxygen consumption that is available for the end of a skin carcinogenesis study [28]. In this study, cells to use in times of stress or increased ATP demand, we identified that PFKFB2 was upregulated in skin was calculated by subtracting basal respiration from tumor tissues of the wild-type mice but not in the UCP2 maximal respiration (FCCP). As shown in Figure 1A, knockout mice, suggesting that PFKFB2 expression may reserve capacity was significantly decreased in the UCP2 be positively regulated by UCP2 [28]. PFKFBs are a overexpressed cells compared to the control pCMV cells family of bifunctional enzymes that control the levels of and TPA treatment further reduced the reserve capacity. fructose 2,6-bisphosphate (Fru-2,6-P2). They are termed These results show that OCR is significantly dampened ‘bifunctional’ because they catalyze the synthesis and in UCP2 overexpressed cells. To determine whether the degradation of Fru-2,6-P2. Fru-2,6-P2 is a powerful the decreased OCR was compensated with an elevated allosteric activator of 6-phosphofructo-1-kinase (PFK- glycolytic rate, ECAR was also measured in these cells. 1), a key enzyme in controlling the glycolytic flux. As shown in Figure 1B, in contrast to the OCR results, PFK-1 catalyzes the conversion of Fru-6-P (fructose 6- glycolysis was at maximum in the presence of glucose in phosphate) into Fru-1,6-P2. [29–30]. Therefore, increased the UCP2 overexpressed cells and TPA treatment further levels of Fru-2,6-P2 would allow cells to maintain a high elevated the glycolytic rates. Basal glycolysis, glycolytic glycolytic flux. In mammals, there are four isoforms of capacity, and glycolytic reserve in UCP2 overexpressed PFKFB genes (PFKFB1, PFKB2, PFKFB3, and PFKB4) cells were significantly higher than that of control pCMV which are characterized by tissue expression [31]. In fact, cells. Therefore, both the OCR and ECAR data together PFKFB2, PFKFB3, and PFKFB4 are overexpressed in the suggest that mitochondrial respiration is dampened, majority cancers, leading to a higher concentration of Fru- whereas glycolysis is enhanced in UCP2 overexpressed 2,6-P2 and increased glycolytic flux to lactate [32–34]. cells; therefore, UCP2 overexpression may cause a switch Given that PFKFB2 was activated in wild-type from mitochondrial respiration to glycolysis. Furthermore, mice but not in UCP2 knockout mice during the skin intracellular ATP levels were elevated in the UCP2 carcinogenesis study [28], we speculated that UCP2 overexpressed cells (Figure 1C), suggesting that UCP2 overexpression may bring a metabolic shift towards overexpression may serve as an important bioenergetic glycolysis by activating PFKFB2 as a potential novel regulator which enhances glycolysis to produce more mechanism of tumor promotion. Utilizing the well- ATP to meet the need for proliferation. The increase in the established JB6 skin cell transformation model, we have levels of lactate (Figure 1D) in the UCP2 overexpressed performed mechanistic studies to determine whether cells is further confirmation of the Warburg effect PFKFB2 activation is important for skin tumorigenesis observed in UCP2 overexpressed cells. and how UCP2 overexpression regulated PFKFB2 activation. www.impactjournals.com/oncotarget
Load more

Recommended publications
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • Small-Molecule Inhibition of 6-Phosphofructo-2-Kinase Activity Suppresses Glycolytic Flux and Tumor Growth
    110 Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth Brian Clem,1,3 Sucheta Telang,1,3 Amy Clem,1,3 reduces the intracellular concentration of Fru-2,6-BP, Abdullah Yalcin,1,2,3 Jason Meier,2 glucose uptake, and growth of established tumors in vivo. Alan Simmons,1,3 Mary Ann Rasku,1,3 Taken together, these data support the clinical development Sengodagounder Arumugam,1,3 of 3PO and other PFKFB3 inhibitors as chemotherapeutic William L. Dean,2,3 John Eaton,1,3 Andrew Lane,1,3 agents. [Mol Cancer Ther 2008;7(1):110–20] John O. Trent,1,2,3 and Jason Chesney1,2,3 Departments of 1Medicine and 2Biochemistry and Molecular Introduction Biology and 3Molecular Targets Group, James Graham Brown Neoplastic transformation causes a marked increase in Cancer Center, University of Louisville, Louisville, Kentucky glucose uptake and catabolic conversion to lactate, which forms the basis for the most specific cancer diagnostic 18 Abstract examination—positron emission tomography of 2- F- fluoro-2-deoxyglucose (18F-2-DG) uptake (1). The protein 6-Phosphofructo-1-kinase, a rate-limiting enzyme of products of several oncogenes directly increase glycolytic glycolysis, is activated in neoplastic cells by fructose-2,6- flux even under normoxic conditions, a phenomenon bisphosphate (Fru-2,6-BP), a product of four 6-phospho- originally termed the Warburg effect (2, 3). For example, fructo-2-kinase/fructose-2,6-bisphosphatase isozymes c-myc is a transcription factor that promotes the expression (PFKFB1-4). The inducible PFKFB3 isozyme is constitu- of glycolytic enzyme mRNAs, and its expression is increased tively expressed by neoplastic cells and required for the in several human cancers regardless of the oxygen pressure high glycolytic rate and anchorage-independent growth of (4, 5).
    [Show full text]
  • Open Full Page
    Published OnlineFirst February 12, 2018; DOI: 10.1158/0008-5472.CAN-17-2215 Cancer Metabolism and Chemical Biology Research RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma Thibault Houles1, Simon-Pierre Gravel2,Genevieve Lavoie1, Sejeong Shin3, Mathilde Savall1, Antoine Meant 1, Benoit Grondin1, Louis Gaboury1,4, Sang-Oh Yoon3, Julie St-Pierre2, and Philippe P. Roux1,4 Abstract Metabolic reprogramming is a hallmark of cancer that includes glycolytic flux in melanoma cells, suggesting an important role for increased glucose uptake and accelerated aerobic glycolysis. This RSK in BRAF-mediated metabolic rewiring. Consistent with this, phenotypeisrequiredtofulfill anabolic demands associated with expression of a phosphorylation-deficient mutant of PFKFB2 aberrant cell proliferation and is often mediated by oncogenic decreased aerobic glycolysis and reduced the growth of melanoma drivers such as activated BRAF. In this study, we show that the in mice. Together, these results indicate that RSK-mediated phos- MAPK-activated p90 ribosomal S6 kinase (RSK) is necessary to phorylation of PFKFB2 plays a key role in the metabolism and maintain glycolytic metabolism in BRAF-mutated melanoma growth of BRAF-mutated melanomas. cells. RSK directly phosphorylated the regulatory domain of Significance: RSK promotes glycolytic metabolism and the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (PFKFB2), growth of BRAF-mutated melanoma by driving phosphory- an enzyme that catalyzes the synthesis of fructose-2,6-bisphosphate lation of an important glycolytic enzyme. Cancer Res; 78(9); during glycolysis. Inhibition of RSK reduced PFKFB2 activity and 2191–204. Ó2018 AACR. Introduction but recently developed therapies that target components of the MAPK pathway have demonstrated survival advantage in pati- Melanoma is the most aggressive form of skin cancer and arises ents with BRAF-mutated tumors (7).
    [Show full text]
  • Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: an Update
    International Journal of Molecular Sciences Review Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update Philippe Icard 1,2,3,*, Antoine Coquerel 1,4, Zherui Wu 5 , Joseph Gligorov 6, David Fuks 7, Ludovic Fournel 3,8, Hubert Lincet 9,10 and Luca Simula 11 1 Medical School, Université Caen Normandie, CHU de Caen, 14000 Caen, France; [email protected] 2 UNICAEN, INSERM U1086 Interdisciplinary Research Unit for Cancer Prevention and Treatment, Normandie Université, 14000 Caen, France 3 Service de Chirurgie Thoracique, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 4 INSERM U1075, COMETE Mobilités: Attention, Orientation, Chronobiologie, Université Caen, 14000 Caen, France 5 School of Medicine, Shenzhen University, Shenzhen 518000, China; [email protected] 6 Oncology Department, Tenon Hospital, Pierre et Marie Curie University, 75020 Paris, France; [email protected] 7 Service de Chirurgie Digestive et Hépato-Biliaire, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 8 Descartes Faculty of Medicine, University of Paris, Paris Center, 75006 Paris, France 9 INSERM U1052, CNRS UMR5286, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; [email protected] 10 ISPB, Faculté de Pharmacie, Université Lyon 1, 69373 Lyon, France 11 Department of Infection, Immunity and Inflammation, Institut Cochin, INSERM U1016, CNRS UMR8104, Citation: Icard, P.; Coquerel, A.; Wu, University of Paris, 75014 Paris, France; [email protected] Z.; Gligorov, J.; Fuks, D.; Fournel, L.; * Correspondence: [email protected] Lincet, H.; Simula, L.
    [Show full text]
  • Vitamin K2 Promotes PI3K/AKT/HIF-1Α-Mediated
    www.nature.com/scientificreports OPEN Vitamin K2 promotes PI3K/AKT/ HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells Fengsen Duan1, Chunlei Mei2, Luhao Yang2, Junyan Zheng2, Huiai Lu1, Yanzhi Xia1, Stacy Hsu4, Huageng Liang3 ✉ & Ling Hong1 ✉ Vitamin K2 has been shown to exert remarkable anticancer activity. However, the detailed mechanism remains unclear. Here, our study was the frst to show that Vitamin K2 signifcantly promoted the glycolysis in bladder cancer cells by upregulating glucose consumption and lactate production, whereas inhibited TCA cycle by reducing the amounts of Acetyl-CoA. Moreover, suppression of PI3K/ AKT and HIF-1α attenuated Vitamin K2-increased glucose consumption and lactate generation, indicating that Vitamin K2 promotes PI3K/AKT and HIF-1α-mediated glycolysis in bladder cancer cells. Importantly, upon glucose limitation, Vitamin K2-upregulated glycolysis markedly induced metabolic stress, along with AMPK activation and mTORC1 pathway suppression, which subsequently triggered AMPK-dependent autophagic cell death. Intriguingly, glucose supplementation profoundly abrogated AMPK activation and rescued bladder cancer cells from Vitamin K2-triggered autophagic cell death. Furthermore, both inhibition of PI3K/AKT/HIF-1α and attenuation of glycolysis signifcantly blocked Vitamin K2-induced AMPK activation and subsequently prevented autophagic cell death. Collectively, these fndings reveal that Vitamin K2 could induce metabolic stress and trigger AMPK-dependent autophagic cell death in bladder cancer cells by PI3K/AKT/HIF-1α-mediated glycolysis promotion. Cancer cells, including bladder carcinoma cells, display the altered metabolism, compared to normal cells1. One of the most metabolic shifs in cancer cells is the aberrant glucose metabolism.
    [Show full text]
  • 6-Phosphofructo-2-Kinase/Fructose-2
    Published OnlineFirst August 7, 2019; DOI: 10.1158/1078-0432.CCR-18-3448 Translational Cancer Mechanisms and Therapy Clinical Cancer Research 6-Phosphofructo-2-Kinase/Fructose-2,6- Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers Hailing Yang1, Zhang Shu1,2,Yongying Jiang3, Weiqun Mao1, Lan Pang1, Abena Redwood4, Sabrina L. Jeter-Jones4, Nicholas B. Jennings5, Argentina Ornelas6, Jinhua Zhou1, Cristian Rodriguez-Aguayo1,7, Geoffrey Bartholomeusz1, LaKesla R. Iles1, Niki M. Zacharias8, Steven W. Millward6, Gabriel Lopez-Berestein1,7, Xiao-Feng Le1, Ahmed A. Ahmed9,10, Helen Piwnica-Worms4, Anil K. Sood5,7, Robert C. Bast1, and Zhen Lu1 Abstract Purpose: Paclitaxel is an integral component of primary Results: Knockdown of PFKFB2 inhibited clonogenic therapy for breast and epithelial ovarian cancers, but less than growth and enhanced paclitaxel sensitivity in ovarian and half of these cancers respond to the drug. Enhancing the breast cancer cell lines with wild-type TP53 (wtTP53). response to primary therapy with paclitaxel could improve Silencing PFKFB2 significantly inhibited tumor growth and outcomes for women with both diseases. enhanced paclitaxel sensitivity in four xenografts derived Experimental Design: Twelve kinases that regulate from two ovarian and two breast cancer cell lines, and metabolism were depleted in multiple ovarian and breast prolonged survival in a triple-negative breast cancer PDX. cancer cell lines to determine whether they regulate sensi- Transfection of siPFKFB2 increased the glycolysis rate, but tivity to paclitaxel in Sulforhodamine B assays. The effects decreased the flow of intermediates through the pentose– of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase phosphate pathway in cancer cells with wtTP53,decreasing 2(PFKFB2) depletion on cell metabolomics, extracellular NADPH.
    [Show full text]
  • Bioenergetic Abnormalities in Schizophrenia
    Bioenergetic abnormalities in schizophrenia A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate Program in Neuroscience of the College of Medicine by Courtney René Sullivan B.S. University of Pittsburgh, 2013 Dissertation Committee: Mark Baccei, Ph.D. (chair) Robert McCullumsmith, M.D., Ph.D. (advisor) Michael Lieberman, Ph.D. Temugin Berta, Ph.D. Robert McNamara, Ph.D. ABSTRACT Schizophrenia is a devastating illness that affects over 2 million people in the U.S. and displays a wide range of psychotic symptoms, as well as cognitive deficits and profound negative symptoms that are often treatment resistant. Cognition is intimately related to synaptic function, which relies on the ability of cells to obtain adequate amounts of energy. Studies have shown that disrupting bioenergetic pathways affects working memory and other cognitive behaviors. Thus, investigating bioenergetic function in schizophrenia could provide important insights into treatments or prevention of cognitive disorders. There is accumulating evidence of bioenergetic dysfunction in chronic schizophrenia, including deficits in energy storage and usage in the brain. However, it is unknown if glycolytic pathways are disrupted in this illness. This dissertation employs a novel reverse translational approach to explore glycolytic pathways in schizophrenia, effectively combining human postmortem studies with bioinformatic analyses to identify possible treatment strategies, which we then examine in an animal model. To begin, we characterized a major pathway supplying energy to neurons (the lactate shuttle) in the dorsolateral prefrontal cortex (DLPFC) in chronic schizophrenia. We found a significant decrease in the activity of two key glycolytic enzymes in schizophrenia (hexokinase, HXK and phosphofructokinase, PFK), suggesting a decrease in the capacity to generate bioenergetic intermediates through glycolysis in this illness.
    [Show full text]
  • Glycolytic Reliance Promotes Anabolism in Photoreceptors
    bioRxiv preprint doi: https://doi.org/10.1101/101964; this version posted January 21, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Glycolytic reliance promotes anabolism in photoreceptors Yashodhan Chinchore, Tedi Begaj, David Wu, Eugene Drokhlyansky, Constance L. Cepko* *Departments of Genetics and Ophthalmology, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115, USA [email protected] bioRxiv preprint doi: https://doi.org/10.1101/101964; this version posted January 21, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Sensory neurons capture information from the environment and convert it 2 into signals that can greatly impact the survival of an organism. These systems 3 are thus under heavy selective pressure, including for the most efficient use of 4 energy to support their sensitivity and efficiency1. In this regard, the 5 vertebrate photoreceptor cells face a dual challenge. They not only need to 6 preserve their membrane excitability via ion pumps by ATP hydrolysis2 but 7 also maintain a highly membrane rich organelle, the outer segment, which is 8 the primary site of phototransduction, creating a considerable biosynthetic 9 demand. How photoreceptors manage carbon allocation to balance their 10 catabolic and anabolic demands is poorly understood. One metabolic feature 11 of the retina is its ability to convert the majority of its glucose into lactate3,4 12 even in the presence of oxygen.
    [Show full text]
  • 13064 Phospho-PFKFB2 (Ser483) (D4R1W) Rabbit Mab
    Revision 1 C 0 2 - t Phospho-PFKFB2 (Ser483) (D4R1W) a e r o t Rabbit mAb S Orders: 877-616-CELL (2355) [email protected] 4 Support: 877-678-TECH (8324) 6 0 Web: [email protected] 3 www.cellsignal.com 1 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source/Isotype: UniProt ID: Entrez-Gene Id: WB H Endogenous 55 Rabbit IgG O60825 5208 Product Usage Information Application Dilution Western Blotting 1:1000 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity Phospho-PFKFB2 (Ser483) (D4R1W) Rabbit mAb recognizes endogenous levels of PFKFB2 protein only when phosphorylated at Ser483. Species Reactivity: Human Species predicted to react based on 100% sequence homology: Mouse, Rat Source / Purification Monoclonal antibody is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser483 of human PFKFB2 protein. Background The bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK/FBPase or PFKFB) catalyzes the synthesis and degradation of fructose 2,6-bisphosphate and regulates its steady-state level (1,2). Fructose 2,6-bisphosphate activates phosphofructokinase, a rate-limiting enzyme in glycolysis, by allosteric regulation (1,2). Four different PFKFB isoforms (PFKFB1, PFKFB2, PFKFB3, and PFKFB4) have been identified (1,2). Research studies indicate that amino acids activate PFKFB2 through Akt- dependent phosphorylation at Ser483 on PFKFB2 (3).
    [Show full text]
  • Oxidative Stress-Responsive Microrna-320 Regulates Glycolysis in Diverse Biological Systems
    The FASEB Journal • Research Communication Oxidative stress-responsive microRNA-320 regulates glycolysis in diverse biological systems ʈ ʈ ʈ ʈ Huibin Tang,*, Myung Lee,*, Orr Sharpe,†,‡, Louis Salamone,† Emily J. Noonan,§, ʈ ʈ Chuong D. Hoang,*, Sanford Levine,¶ William H. Robinson,†,‡, ʈ and Joseph B. Shrager*, ,1 *Division of Thoracic Surgery, Department of Cardiothoracic Surgery, †Department of Surgery, and ‡Division of Immunology and Rheumatology and §Division of Hematology; Department of Medicine, ʈ Stanford University School of Medicine, Stanford, California, USA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA; and ¶Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA ABSTRACT Glycolysis is the initial step of glucose glycolysis in diverse biological systems. FASEB J. 26, catabolism and is up-regulated in cancer cells (the 4710–4721 (2012). www.fasebj.org Warburg Effect). Such shifts toward a glycolytic phenotype have not been explored widely in other Key Words: phosphofructokinase ⅐ muscle ⅐ diaphragm ⅐ biological systems, and the molecular mechanisms mechanical ventilation ⅐ Warburg effect ⅐ Ets underlying the shifts remain unknown. With pro- teomics, we observed increased glycolysis in disused Cells use glucose to generate the energy [adeno- human diaphragm muscle. In disused muscle, lung sine triphosphate (ATP)] that fuels all cellular pro- cancer, and H O -treated myotubes, we show up- 2 2 cesses. Glycolysis is the initial step in glucose catabo- regulation of the rate-limiting glycolytic enzyme mus- lism, and its end products, in most tissues under most cle-type phosphofructokinase (PFKm, >2 fold, circumstances, are fed into mitochondrial oxidative P<0.05) and accumulation of lactate (>150%, phosphorylation.
    [Show full text]
  • Mutation of Regulatory Phosphorylation Sites in PFKFB2 Worsens Renal Fbrosis Mardiana Lee1,2, Geof Harley1,2, Marina Katerelos1, Kurt Gleich1, Mitchell A
    www.nature.com/scientificreports OPEN Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fbrosis Mardiana Lee1,2, Geof Harley1,2, Marina Katerelos1, Kurt Gleich1, Mitchell A. Sullivan3, Adrienne Laskowski4, Melinda Coughlan4, Scott A. Fraser1, Peter F. Mount1,2,5 & David A. Power1,2,5* Fatty acid oxidation is the major energy pathway used by the kidney, although glycolysis becomes more important in the low oxygen environment of the medulla. Fatty acid oxidation appears to be reduced in renal fbrosis, and drugs that reverse this improve fbrosis. Expression of glycolytic genes is more variable, but some studies have shown that inhibiting glycolysis reduces renal fbrosis. To address the role of glycolysis in renal fbrosis, we have used a genetic approach. The crucial control point in the rate of glycolysis is 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase. Phosphorylation of the kidney isoform, PFKFB2, on residues Ser468 and Ser485 stimulates glycolysis and is the most important mechanism regulating glycolysis. We generated transgenic mice with inactivating mutations of Ser468 and Ser485 in PFKFB2 (PFKFB2 KI mice). These mutations were associated with a reduced ability to increase glycolysis in primary cultures of renal tubular cells from PFKFB2 KI mice compared to WT cells. This was associated in PFKFB2 KI mice with increased renal fbrosis, which was more severe in the unilaternal ureteric obstruction (UUO) model compared with the folic acid nephropathy (FAN) model. These studies show that phosphorylation of PFKFB2 is important in limiting renal fbrosis after injury, indicating that the ability to regulate and maintain adequate glycolysis in the kidney is crucial for renal homeostasis.
    [Show full text]
  • Cyclin and Growth Arrest-Specific Genes
    ISSN: 0975-8585 Research Journal of Pharmaceutical, Biological and Chemical Sciences Expression of Genes Encoded 6-phosphofructo-2-kinase/fructose-2, 6- bisphosphatase and 6-phosphofructo-1-kinase in U87 Glioma Cells with ERN1 Loss of Function: Hypoxic Regulation 1,2Minchenko DM, 1Lypova NM, 1Harmash YA, 3Kulinich AO, 1Marunych RY, 1Karbovskyi LL, 1*Minchenko ОH 1Palladin Institute of Biochemistry National Academy of Science of Ukraine, Kyiv, Ukraine. 2National O.O. Bohomolets Medical University, Kyiv 01601, Ukraine. 3Dnipropetrovs’k State Medical Academy, Dnipropetrovs’k 49600, Ukraine. ABSTRACT The endoplasmic reticulum–nuclei-1 (ERN1) sensing and signaling enzyme mediates a set of complex intracellular signaling events known as the unfolded protein response. We have studied the effect of hypoxia on the expression of genes encoded different 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB1, PFKFB2, PFKFB3 and PFKFB4) and 6-phosphofructo-1-kinase (PFKL, PFKM and PFKP) as well as lactate dehydrogenase (LDHA) in glioma U87 cells and its subline with suppressed function of ERN1 signaling enzyme. It was shown that blockade a function of ERN1 enzyme, the key endoplasmic reticulum stress sensor, leads to an increase in the expression levels of PFKFB1, PFKFB2, PFKFB3 and PFKFB4 mRNA, being more significant for PFKFB4 and PFKFB2. Moreover, the expression level of PFKL and PFKP as well as LDHA mRNA also increases in cells with ERN1 loss of function, being more significant for PFKL. At the same time, the expression level of PFKM mRNA significantly decreases at this experimental condition. Exposure cells under hypoxic conditions leads to an increase of the expression level of PFKFB3 and PFKFB4 mRNA both in control glioma cells and cells with ERN1 loss of function, being more significant for PFKFB4.
    [Show full text]